Crossmark

Change in mammographic density as a potential predictor of cancer recurrence after breast conservation surgery and adjuvant endocrine therapy: results of the MEDICI study

Crossref DOI link: https://doi.org/10.1186/s13058-026-02239-2

Published Online: 2026-02-19

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Savaridas, Sarah L

Marshall, Andrea

Ali, Kulsam

Astley, Susan M

Evans, Andrew J

Halling-Brown, Mark

Vinnicombe, Sarah

Warwick, Violet R

Whelehan, Patsy

Drummond, Sonya

Ebsim, Raja

Healy, Nuala A

Nash, Jonathan

Muscat, Elizabeth

Muthyala, Sreenivas

Sharma, Ashwini

Telesca, Marianna

Dunn, Janet
Funding

Funding for this research was provided by:

Breast Cancer Now (2018JULPR1125)

Breast Cancer Now (2018JULPR1125)

Breast Cancer Now (2018JULPR1125)

Breast Cancer Now (2018JULPR1125)

Breast Cancer Now (2018JULPR1125)

Breast Cancer Now (2018JULPR1125)

Breast Cancer Now (2018JULPR1125)

Breast Cancer Now (2018JULPR1125)
License Information

Text and Data Mining valid from 2026-02-19

Version of Record valid from 2026-03-26
More Information

Article History

Received: 19 August 2025

Accepted: 7 February 2026

First Online: 19 February 2026

Declarations

:

: • Mammo-50 was approved by the UK Health Research Authority (HRA) (West Midlands Research Ethics Committee 13/WM/0419). Patients gave written consent for their data to be used in future research. MEDICI was also approved by the UK HRA (CAG: 19/CAG/0149, REC: 19/WS/0112).

: • Not applicable.

: The authors declare no competing interests.

Document is current

Any future updates will be listed below